• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    FIGS Releases Third Quarter 2024 Financial Results

    11/7/24 4:05:00 PM ET
    $FIGS
    Apparel
    Consumer Discretionary
    Get the next $FIGS alert in real time by email

    Completed State-of-the-Art Fulfillment Center Transition

    Announces Minority Investment in OOG, Inc., A New Online Platform for Healthcare Professionals

    Updates Full Year 2024 Outlook

    FIGS, Inc. (NYSE:FIGS) (the "Company"), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released its third quarter 2024 financial results and published a financial highlights presentation on its investor relations website at ir.wearfigs.com/financials/quarterly-results.

    Third Quarter 2024 Financial Highlights

    • Net revenues(1) were $140.2 million, a decrease of 1.5% year over year, due to a decrease in average order value ("AOV"),(2) partially offset by an increase in orders from existing customers.
    • Gross margin was 67.1%, a decrease of 1.3% year over year, primarily from higher discounted sales and, to a lesser extent, product mix shift related to limited edition scrubwear.
    • Operating expenses were $102.7 million, an increase of 17.4% year over year. As a percentage of net revenues, operating expenses increased to 73.2% from 61.5% primarily due to higher marketing and selling expenses, including higher digital and brand marketing expenses related to our 2024 Olympics campaign and higher transitory expenses associated with the transition to our new fulfillment center.
    • Net income (loss) and Net income (loss), as adjusted(3) were $(1.7) million (or $(0.01) in diluted earnings per share), a decrease of $7.8 million as compared to net income in the same period last year and a decrease of $8.0 million as compared to net income, as adjusted(3) in the same period last year.
    • Net income (loss) margin(4) was (1.2)%, as compared to 4.2% in the same period last year.
    • Adjusted EBITDA(3) was $4.8 million, a decrease of $19.6 million year over year.
    • Adjusted EBITDA margin(3)(4) was 3.4%, as compared to 17.2% in the same period last year.

    Key Operating Metrics

    • Active customers(2) as of September 30, 2024 increased 3.8% year over year to 2.7 million.
    • Net revenues per active customer(2)(5) were $205, a decrease of 3.3% year over year.
    • AOV(2)(5) was $108, a decrease of 5.3% year over year, primarily driven by a combination of factors including lower units per transaction, higher discounts and returns, and the accounting reclassification between net revenues and selling expense related to duty subsidies for international customers.

    "The third quarter included several key investments to support and scale FIGS, highlighted by our incredible Olympics campaign with the Team USA Medical Team and the completed transition of our fulfillment center to a state-of-the-art, highly-automated facility," said Trina Spear, Chief Executive Officer and Co-Founder. "Our financial performance during the period continued to show positive signs with brand interest and engagement remaining high, newness and innovation resonating, and frequency improving. We also experienced several challenges in the quarter, including the impacts of our footwear inventory and pricing, our promotional timing, and the costs to ramp up our fulfillment center, which we are addressing to further strengthen our performance. Additionally, our focus on a strong balance sheet and cash flow provide ongoing flexibility to invest in our core business, return value to shareholders and find unique ways to disrupt the industry."

    Minority Investment in OOG, Inc.

    The Company also announced that it signed and closed a $25.0 million minority investment in OOG, Inc. ("OOG").

    Expected to launch within the next six months, OOG offers an AI-powered, multi-disciplinary education platform for healthcare professionals. While more details will be announced about OOG when its platform launches, FIGS also expects to work with OOG in ways that will enable FIGS to receive a range of benefits across marketing, community engagement, data and AI. OOG was founded, and is led, by FIGS Co-Founder and Executive Chair Heather Hasson.

    A special committee of the Company's board of directors (the "Board") comprised solely of independent and disinterested directors, evaluated, negotiated and recommended approval of this transaction, which was subsequently approved by the Board. LionTree Advisors LLC acted as financial advisor and Freshfields LLP acted as legal advisor to the special committee. Latham & Watkins LLP acted as legal advisor to the Company.

    "We are thrilled to be investing in and collaborating with OOG," said Ms. Spear. "Much like the original inspiration for FIGS, OOG looks to transform a large, fragmented and outdated industry through AI, technology and a revolutionary platform. We believe that the OOG platform will significantly expand the ways that we can serve our Awesome Humans and, most importantly, improve their experience of being a healthcare professional."

    Financial Outlook

    For Full-Year 2024, the Company now expects:

    Net Revenues growth versus 2023

    Down 1% to flat

     

     

    Adjusted EBITDA Margin(3)(6)

    ~ 8%

    (1) Third quarter 2024 net revenues results reflect $2.0 million in international duty subsidies recorded as contra revenue, whereas international duty subsidies were recorded in selling expense in third quarter 2023. As a result, year over year net revenues growth was negatively impacted by 1.4 percentage points.

    (2) "Active customers," "net revenues per active customer" and "average order value" are key operational and business metrics that are important to understanding the Company's performance. Please see the sections titled "Non-GAAP Financial Measures and Key Operating Metrics" and "Key Operating Metrics" below for information regarding how the Company calculates its key operational and business metrics and for comparisons of active customers, net revenues per active customer and average order value to the prior year period.

    (3) "Net income (loss), as adjusted," "adjusted EBITDA" and "adjusted EBITDA margin" are non-GAAP financial measures. Please see the sections titled "Non-GAAP Financial Measures and Key Operating Metrics" and "Reconciliations of GAAP to Non-GAAP Measures" below for more information regarding the Company's use of non-GAAP financial measures and reconciliations to the most directly comparable GAAP measures.

    (4) "Net income (loss) margin" and "adjusted EBITDA margin" are calculated by dividing net income (loss) and adjusted EBITDA by net revenues, respectively.

    (5) Net revenues per active customer and AOV results for the third quarter 2024 each reflect international duty subsidies recorded as contra revenue, which were not reflected in the results for these metrics for third quarter 2023. As a result, year over year growth in net revenues per active customer and AOV were negatively impacted by approximately 2 and 1 percentage points, respectively.

    (6) The Company has not provided a quantitative reconciliation of its adjusted EBITDA margin outlook to a GAAP net income margin outlook because it is unable, without making unreasonable efforts, to project certain reconciling items. These items include, but are not limited to, future stock-based compensation expense, income taxes, expenses related to non-ordinary course disputes, and transaction costs. These items are inherently variable and uncertain and depend on various factors, some of which are outside of the Company's control or ability to predict. For more information regarding the Company's use of non-GAAP financial measures, please see the section titled "Non-GAAP Financial Measures and Key Operating Metrics."

    Conference Call Details

    FIGS management will host a conference call and webcast today at 2:00 p.m. PT / 5:00 p.m. ET to discuss the Company's financial and business results and outlook. To participate, please dial 1-833-470-1428 (US) or +1-404-975-4839 (International) and the conference ID 452177. The call is also accessible via webcast at ir.wearfigs.com. A recording will be available shortly after the conclusion of the call through November 14, 2024. To access the replay, please dial 1-866-813-9403 (US) or +1-929-458-6194 (International) and the conference ID 984524. An archive of the webcast will be available on FIGS' investor relations website at ir.wearfigs.com.

    Non-GAAP Financial Measures and Key Operating Metrics

    In addition to the GAAP financial measures set forth in this press release, the Company has included non-GAAP financial measures within the meaning of Regulation G and Item 10(e) of Regulation S-K. The Company uses "net income (loss), as adjusted," "diluted earnings per share, as adjusted," "adjusted EBITDA" and "adjusted EBITDA margin" to provide useful supplemental measures that assist in evaluating its ability to generate earnings, provide consistency and comparability with its past financial performance and facilitate period-to-period comparisons of its core operating results as well as the results of its peer companies. The Company uses "free cash flow" as a useful supplemental measure of liquidity and as an additional basis for assessing its ability to generate cash. The Company calculates "net income (loss), as adjusted," as net income (loss) adjusted to exclude transaction costs, expenses related to non-ordinary course disputes, other than temporary impairment of held-to-maturity investments, stock-based compensation, including expense related to award modifications, accelerated performance awards and associated payroll taxes and costs, ambassador grants in connection with its initial public offering, and expense resulting from the retirement of a former CFO of the Company, and the income tax impact of these adjustments. The Company calculates "diluted earnings per share, as adjusted" as net income (loss), as adjusted divided by diluted shares outstanding. The Company calculates "adjusted EBITDA" as net income (loss) adjusted to exclude: other income (loss), net; gain/loss on disposal of assets; provision for income taxes; depreciation and amortization expense; stock-based compensation and related expense; transaction costs; and expenses related to non-ordinary course disputes. The Company calculates "adjusted EBITDA margin" by dividing adjusted EBITDA by net revenues. The Company calculates "free cash flow" as net cash (used in) provided by operating activities reduced by capital expenditures, including purchases of property and equipment and capitalized software development costs.

    Reconciliations of non-GAAP financial measures to the most directly comparable GAAP measures are included below under the heading "Reconciliations of GAAP to Non-GAAP Measures."

    The Company has also included herein "active customers," "net revenues per active customer" and "average order value," which are key operational and business metrics that are important to understanding Company performance. The Company believes the number of active customers is an important indicator of growth as it reflects the reach of the Company's digital platform, brand awareness and overall value proposition. The Company defines an active customer as a unique customer account that has made at least one purchase in the preceding 12-month period. In any particular period, the Company determines the number of active customers by counting the total number of customers who have made at least one purchase in the preceding 12-month period, measured from the last date of such period. The Company believes measuring net revenues per active customer is important to understanding engagement and retention of customers, and as such, the value proposition for its customer base. The Company defines net revenues per active customer as the sum of total net revenues in the preceding 12-month period divided by the current period active customers. The Company defines average order value as the sum of the total net revenues in a given period divided by the total orders placed in that period. Total orders are the summation of all completed individual purchase transactions in a given period. The Company believes its relatively high average order value demonstrates the premium nature of its products. As the Company expands into and increases its presence in additional product categories, price points and international markets, average order value may fluctuate.

    Active customers as of September 30, 2024 and 2023, respectively, net revenues per active customer as of September 30, 2024 and 2023, respectively, and average order value for the three and nine months ended September 30, 2024 and 2023, respectively, are presented below under the heading "Key Operating Metrics."

    About FIGS

    FIGS is a founder-led, direct-to-consumer healthcare apparel and lifestyle brand that seeks to celebrate, empower, and serve current and future generations of healthcare professionals. We create technically advanced apparel and products that feature an unmatched combination of comfort, durability, function, and style. We share stories about healthcare professionals' experiences in ways that inspire them. We build meaningful connections within the healthcare community that we created. Above all, we seek to make an impact for our community, including by advocating for them and always having their backs.

    We serve healthcare professionals in numerous countries in North America, Europe, the Asia Pacific region and the Middle East. We also serve healthcare institutions through our TEAMS platform.

    Forward Looking Statements

    This press release contains various forward-looking statements about the Company within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, that are based on current management expectations, and which involve substantial risks and uncertainties that could cause actual results to differ materially from the results expressed in, or implied by, such forward-looking statements. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking. These forward-looking statements generally are identified by the words "anticipate", "believe", "contemplate", "continue", "could", "estimate", "expect", "forecast", "future", "intend", "may", "might", "opportunity", "outlook", "plan", "possible", "potential", "predict", "project," "should", "strategy", "strive", "target", "will" or "would", the negative of these words or other similar terms or expressions. The absence of these words does not mean that a statement is not forward-looking. These forward-looking statements address various matters, including the Company's plans to address challenges experienced in the quarter ended September 30, 2024; the Company's ongoing flexibility to invest in its core business, return value to shareholders and find unique ways to disrupt the industry; the expected timing of OOG's launch and for additional details about the platform to be announced; the Company's expectation of working with OOG and the benefits it expects to receive, including as to marketing, community engagement and AI; OOG's plan to transform an outdated industry; the Company's belief that the OOG platform will significantly expand the ways that it can serve its community; and the Company's outlook as to net revenues growth and adjusted EBITDA margin for the full year ending December 31, 2024; all of which reflect the Company's expectations based upon currently available information and data. Because such statements are based on expectations as to future financial and operating results and are not statements of fact, the Company's actual results, performance or achievements may differ materially from those expressed or implied by the forward-looking statements, and you are cautioned not to place undue reliance on these forward-looking statements. The following important factors and uncertainties, among others, could cause actual results, performance or achievements to differ materially from those described in these forward-looking statements: the Company's ability to maintain its historical growth; the Company's ability to maintain profitability; the Company's ability to maintain the value and reputation of its brand; the Company's ability to attract new customers, retain existing customers, and to maintain or increase sales to those customers; the success of the Company's marketing efforts; the Company's ability to maintain a strong community of engaged customers and Ambassadors; negative publicity related to the Company's marketing efforts or use of social media; the Company's ability to successfully develop and introduce new, innovative and updated products; the competitiveness of the market for healthcare apparel; the Company's ability to maintain its key employees; the Company's ability to attract and retain highly skilled team members; risks associated with expansion into, and conducting business in, international markets; changes in, or disruptions to, the Company's shipping arrangements; the successful operation of the Company's distribution and warehouse management systems; the Company's ability to accurately forecast customer demand, manage its inventory, and plan for future expenses; the impact of changes in consumer confidence, shopping behavior and consumer spending on demand for the Company's products; the impact of macroeconomic trends on the Company's operations; the Company's reliance on a limited number of third-party suppliers; the fluctuating costs of raw materials; the Company's failure to protect proprietary, confidential or sensitive information or personal customer data, or risks of cyberattacks; the Company's failure to protect its intellectual property rights; the fact that the operations of many of the Company's suppliers and vendors are subject to additional risks that are beyond its control; and other risks, uncertainties, and factors discussed in the "Risk Factors" section of the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 to be filed with the Securities and Exchange Commission ("SEC"), the Company's Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on February 28, 2024, and the Company's other periodic filings with the SEC. The forward-looking statements in this press release speak only as of the time made and the Company does not undertake to update or revise them to reflect future events or circumstances.

    FIGS, INC.

     

    BALANCE SHEETS

    (In thousands, except share and per share data)

     

     

    As of

     

    September 30,

    2024

     

    December 31,

    2023

    Assets

    (Unaudited)

     

     

    Current assets

     

     

     

    Cash and cash equivalents

    $

    124,103

     

    $

    144,173

    Short-term investments

     

    157,607

     

     

    102,522

    Accounts receivable

     

    10,499

     

     

    7,469

    Inventory, net

     

    123,396

     

     

    119,040

    Prepaid expenses and other current assets

     

    18,689

     

     

    12,455

    Total current assets

     

    434,294

     

     

    385,659

    Non-current assets

     

     

     

    Property and equipment, net

     

    35,395

     

     

    24,864

    Operating lease right-of-use assets

     

    52,769

     

     

    43,059

    Deferred tax assets

     

    17,870

     

     

    18,291

    Other assets

     

    2,160

     

     

    1,336

    Total non-current assets

     

    108,194

     

     

    87,550

    Total assets

    $

    542,488

     

    $

    473,209

    Liabilities and stockholders' equity

     

     

     

    Current liabilities

     

     

     

    Accounts payable

    $

    27,399

     

    $

    14,749

    Operating lease liabilities

     

    11,849

     

     

    8,230

    Accrued expenses

     

    29,036

     

     

    7,906

    Accrued compensation and benefits

     

    5,407

     

     

    7,312

    Sales tax payable

     

    4,250

     

     

    3,149

    Gift card liability

     

    7,944

     

     

    8,240

    Deferred revenue

     

    3,883

     

     

    2,160

    Returns reserve

     

    4,632

     

     

    2,989

    Income tax payable

     

    345

     

     

    2,557

    Total current liabilities

     

    94,745

     

     

    57,292

    Non-current liabilities

     

     

     

    Operating lease liabilities, non-current

     

    44,050

     

     

    38,884

    Other non-current liabilities

     

    183

     

     

    183

    Total liabilities

    $

    138,978

     

    $

    96,359

    Commitments and contingencies

     

     

     

    Stockholders' equity

     

     

     

    Class A Common stock — par value $0.0001 per share, 1,000,000,000 shares authorized as of September 30, 2024 and December 31, 2023; 161,292,723 and 161,457,403 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively

     

    16

     

     

    16

    Class B Common stock — par value $0.0001 per share, 150,000,000 shares authorized as of September 30, 2024 and December 31, 2023; 8,283,641 shares issued and outstanding as of September 30, 2024 and December 31, 2023

     

    —

     

     

    —

    Preferred stock — par value $0.0001 per share, 100,000,000 shares authorized as of September 30, 2024 and December 31, 2023; zero shares issued and outstanding as of September 30, 2024 and December 31, 2023

     

    —

     

     

    —

    Additional paid-in capital

     

    340,684

     

     

    315,075

    Accumulated other comprehensive income

     

    221

     

     

    5

    Retained earnings

     

    62,589

     

     

    61,754

    Total stockholders' equity

     

    403,510

     

     

    376,850

    Total liabilities and stockholders' equity

    $

    542,488

     

    $

    473,209

    FIGS, INC.

     

    STATEMENTS OF OPERATIONS

    (In thousands, except share and per share data)

    (Unaudited)

     

     

    Three months ended September 30,

     

    Nine months ended September 30,

     

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

     

    2023

     

    Net revenues

    $

    140,209

     

     

    $

    142,364

     

     

    $

    403,726

     

     

    $

    400,728

     

    Cost of goods sold

     

    46,181

     

     

     

    44,971

     

     

     

    130,299

     

     

     

    121,625

     

    Gross profit

     

    94,028

     

     

     

    97,393

     

     

     

    273,427

     

     

     

    279,103

     

    Operating expenses

     

     

     

     

     

     

     

    Selling

     

    38,599

     

     

     

    32,195

     

     

     

    103,992

     

     

     

    97,092

     

    Marketing

     

    28,529

     

     

     

    19,012

     

     

     

    68,778

     

     

     

    56,965

     

    General and administrative

     

    35,529

     

     

     

    36,232

     

     

     

    107,292

     

     

     

    105,229

     

    Total operating expenses

     

    102,657

     

     

     

    87,439

     

     

     

    280,062

     

     

     

    259,286

     

    Net income (loss) from operations

     

    (8,629

    )

     

     

    9,954

     

     

     

    (6,635

    )

     

     

    19,817

     

    Other income, net

     

     

     

     

     

     

     

    Interest income

     

    2,926

     

     

     

    1,901

     

     

     

    8,603

     

     

     

    4,494

     

    Other income (expense)

     

    2

     

     

     

    (6

    )

     

     

    (8

    )

     

     

    (11

    )

    Total other income, net

     

    2,928

     

     

     

    1,895

     

     

     

    8,595

     

     

     

    4,483

     

    Net income (loss) before provision for income taxes

     

    (5,701

    )

     

     

    11,849

     

     

     

    1,960

     

     

     

    24,300

     

    Provision for income taxes

     

    (4,001

    )

     

     

    5,703

     

     

     

    1,125

     

     

     

    11,663

     

    Net income (loss)

    $

    (1,700

    )

     

    $

    6,146

     

     

    $

    835

     

     

    $

    12,637

     

    Earnings (loss) attributable to Class A and Class B common stockholders

     

     

     

     

     

     

     

    Basic earnings (loss) per share

    $

    (0.01

    )

     

    $

    0.04

     

     

    $

    —

     

     

    $

    0.08

     

    Diluted earnings (loss) per share

    $

    (0.01

    )

     

    $

    0.03

     

     

    $

    —

     

     

    $

    0.07

     

    Weighted-average shares outstanding—basic

     

    170,168,732

     

     

     

    168,668,844

     

     

     

    170,161,922

     

     

     

    167,628,888

     

    Weighted-average shares outstanding—diluted

     

    170,168,732

     

     

     

    181,429,745

     

     

     

    180,614,560

     

     

     

    182,545,627

     

    FIGS, INC.

     

    STATEMENTS OF CASH FLOWS

    (In thousands)

    (Unaudited)

     

     

    Nine months ended

    September 30,

     

     

    2024

     

     

     

    2023

     

    Cash flows from operating activities:

     

     

     

    Net income

    $

    835

     

     

    $

    12,637

     

    Adjustments to reconcile net income to net cash provided by operating activities:

     

     

     

    Depreciation and amortization expense

     

    4,848

     

     

     

    2,128

     

    Deferred income taxes

     

    421

     

     

     

    (1,841

    )

    Non-cash operating lease cost

     

    6,211

     

     

     

    2,138

     

    Stock-based compensation

     

    32,618

     

     

     

    34,305

     

    Accretion of discount on available-for-sale securities

     

    (4,335

    )

     

     

    (897

    )

    Changes in operating assets and liabilities:

     

     

     

    Accrued interest

     

    (385

    )

     

     

    —

     

    Accounts receivable

     

    (3,030

    )

     

     

    550

     

    Inventory

     

    (4,356

    )

     

     

    34,793

     

    Prepaid expenses and other current assets

     

    (7,965

    )

     

     

    (1,563

    )

    Other assets

     

    (824

    )

     

     

    18

     

    Accounts payable

     

    10,828

     

     

     

    (4,092

    )

    Accrued expenses

     

    21,231

     

     

     

    (9,496

    )

    Accrued compensation and benefits

     

    (1,905

    )

     

     

    3,266

     

    Sales tax payable

     

    1,101

     

     

     

    674

     

    Gift card liability

     

    (296

    )

     

     

    807

     

    Deferred revenue

     

    1,723

     

     

     

    551

     

    Returns reserve

     

    1,643

     

     

     

    (818

    )

    Income tax payable

     

    (2,212

    )

     

     

    9,670

     

    Operating lease liabilities

     

    (5,405

    )

     

     

    (2,183

    )

    Net cash provided by operating activities

     

    50,746

     

     

     

    80,647

     

    Cash flows from investing activities:

     

     

     

    Purchases of property and equipment

     

    (13,658

    )

     

     

    (9,733

    )

    Purchases of available-for-sale securities

     

    (191,379

    )

     

     

    (65,805

    )

    Maturities of available-for-sale securities

     

    141,230

     

     

     

    17,550

     

    Net cash used in investing activities

     

    (63,807

    )

     

     

    (57,988

    )

    Cash flows from financing activities:

     

     

     

    Repurchases of Class A common stock

     

    (7,277

    )

     

     

    —

     

    Proceeds from stock option exercises and employee stock purchases

     

    268

     

     

     

    763

     

    Tax payments related to net share settlements on restricted stock units

     

    —

     

     

     

    (246

    )

    Net cash (used in) provided by financing activities

     

    (7,009

    )

     

     

    517

     

    Net change in cash and cash equivalents

     

    (20,070

    )

     

     

    23,176

     

    Cash and cash equivalents, beginning of period

     

    144,173

     

     

     

    159,775

     

    Cash and cash equivalents, end of period

    $

    124,103

     

     

    $

    182,951

     

    FIGS, INC.

    RECONCILIATIONS OF GAAP TO NON-GAAP MEASURES

    (Unaudited)

    The following table presents a reconciliation of net income (loss), as adjusted to net income (loss), which is the most directly comparable financial measure calculated in accordance with GAAP, and presents diluted earnings per share ("EPS"), as adjusted with diluted EPS:

     

    Three months ended

    September 30,

     

    Nine months ended

    September 30,

     

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

    2023

     

     

    (in thousands, except share and per share amounts)

    Net income (loss)

    $

    (1,700

    )

     

    $

    6,146

     

     

    $

    835

     

    $

    12,637

     

    Add (deduct):

     

     

     

     

     

     

     

    Expenses related to non-ordinary course disputes(1)

     

    —

     

     

     

    —

     

     

     

    —

     

     

    1,256

     

    Stock-based compensation expense in connection with the IPO and other(2)

     

    —

     

     

     

    290

     

     

     

    —

     

     

    290

     

    Income tax impacts of items above

     

    —

     

     

     

    (140

    )

     

     

    —

     

     

    (847

    )

    Net income (loss), as adjusted

    $

    (1,700

    )

     

    $

    6,296

     

     

    $

    835

     

    $

    13,336

     

    Diluted EPS

    $

    (0.01

    )

     

    $

    0.03

     

     

    $

    —

     

    $

    0.07

     

    Diluted EPS, as adjusted

    $

    (0.01

    )

     

    $

    0.03

     

     

    $

    —

     

    $

    0.07

     

    Weighted-average shares used to compute Diluted EPS and Diluted EPS, as adjusted

     

    170,168,732

     

     

     

    181,429,745

     

     

     

    180,614,560

     

     

    182,545,627

     

    (1) Exclusively represents attorney's fees, costs and expenses incurred by the Company in connection with the Company's now-concluded litigation against Strategic Partners, Inc.

    (2) Includes certain stock-based compensation expense in connection with the IPO, including expense related to accelerated performance awards and associated payroll taxes and costs.

    The following table presents a reconciliation of adjusted EBITDA to net income (loss), which is the most directly comparable financial measure calculated in accordance with GAAP, and presents adjusted EBITDA margin with net income (loss) margin, which is the most directly comparable financial measure calculated in accordance with GAAP:

     

    Three months ended

    September 30,

     

    Nine months ended

    September 30,

     

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

     

    2023

     

     

    (in thousands, except margin)

    Net income (loss)

    $

    (1,700

    )

     

    $

    6,146

     

     

    $

    835

     

     

    $

    12,637

     

    Add (deduct):

     

     

     

     

     

     

     

    Other income, net

     

    (2,928

    )

     

     

    (1,895

    )

     

     

    (8,595

    )

     

     

    (4,483

    )

    Provision for income taxes

     

    (4,001

    )

     

     

    5,703

     

     

     

    1,125

     

     

     

    11,663

     

    Depreciation and amortization expense(1)

     

    2,885

     

     

     

    756

     

     

     

    4,848

     

     

     

    2,128

     

    Stock-based compensation and related expense(2)

     

    10,544

     

     

     

    13,713

     

     

     

    32,506

     

     

     

    36,195

     

    Expenses related to non-ordinary course disputes(3)

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    1,256

     

    Adjusted EBITDA

    $

    4,800

     

     

    $

    24,423

     

     

    $

    30,719

     

     

    $

    59,396

     

     

     

     

     

     

     

     

     

    Net revenues

    $

    140,209

     

     

    $

    142,364

     

     

    $

    403,726

     

     

    $

    400,728

     

    Net income (loss) margin(4)

     

    (1.2

    )%

     

     

    4.2

    %

     

     

    0.2

    %

     

     

    3.1

    %

    Adjusted EBITDA margin

     

    3.4

    %

     

     

    17.2

    %

     

     

    7.6

    %

     

     

    14.8

    %

    (1) Excludes amortization of debt issuance costs included in "Other income, net."

    (2) Includes stock-based compensation expense, payroll taxes, and costs related to equity award activity.

    (3) Exclusively represents attorney's fees, costs and expenses incurred by the Company in connection with the Company's now-concluded litigation against Strategic Partners, Inc.

    (4) Net income (loss) margin represents net income (loss) as a percentage of net revenues.

    The following table presents a reconciliation of free cash flow to net cash provided by operating activities, which is the most directly comparable financial measure calculated in accordance with GAAP:

     

    Nine months ended

    September 30,

     

     

    2024

     

     

     

    2023

     

     

    (in thousands)

    Net cash provided by operating activities

    $

    50,746

     

     

    $

    80,647

     

    Less: capital expenditures

     

    (13,658

    )

     

     

    (9,733

    )

    Free cash flow

    $

    37,088

     

     

    $

    70,914

     

    FIGS, INC.

    KEY OPERATING METRICS

    (Unaudited)

    Active customers as of September 30, 2024 and 2023, respectively, net revenues per active customer as of September 30, 2024 and 2023, respectively, and average order value for the three and nine months ended September 30, 2024 and 2023, respectively, are presented in the following tables:

     

    As of September 30,

     

    2024

     

    2023

     

    (in thousands)

    Active customers

    2,673

     

    2,576

     

    As of September 30,

     

     

    2024

     

     

    2023

    Net revenues per active customer

    $

    205

     

    $

    212

     

    Three months ended

    September 30,

     

    Nine months ended

    September 30,

     

     

    2024

     

     

    2023

     

     

    2024

     

     

    2023

    Average order value

    $

    108

     

    $

    114

     

    $

    112

     

    $

    114

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20241107063692/en/

    Get the next $FIGS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FIGS

    DatePrice TargetRatingAnalyst
    11/7/2025$7.00 → $9.00Market Perform
    Telsey Advisory Group
    10/15/2025$9.00Buy
    BTIG Research
    8/8/2025$5.00 → $7.00Market Perform
    Telsey Advisory Group
    5/5/2025$7.00 → $5.00Market Perform
    Telsey Advisory Group
    8/9/2024$6.00 → $7.00Market Perform
    Telsey Advisory Group
    4/2/2024$8.50 → $4.50Neutral → Underperform
    BofA Securities
    3/8/2024Outperform → Perform
    Oppenheimer
    2/29/2024$6.00Outperform → Market Perform
    Telsey Advisory Group
    More analyst ratings

    $FIGS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Telsey Advisory Group reiterated coverage on FIGS, Inc. with a new price target

    Telsey Advisory Group reiterated coverage of FIGS, Inc. with a rating of Market Perform and set a new price target of $9.00 from $7.00 previously

    11/7/25 7:47:45 AM ET
    $FIGS
    Apparel
    Consumer Discretionary

    BTIG Research initiated coverage on FIGS, Inc. with a new price target

    BTIG Research initiated coverage of FIGS, Inc. with a rating of Buy and set a new price target of $9.00

    10/15/25 8:28:19 AM ET
    $FIGS
    Apparel
    Consumer Discretionary

    Telsey Advisory Group reiterated coverage on FIGS, Inc. with a new price target

    Telsey Advisory Group reiterated coverage of FIGS, Inc. with a rating of Market Perform and set a new price target of $7.00 from $5.00 previously

    8/8/25 7:49:08 AM ET
    $FIGS
    Apparel
    Consumer Discretionary

    $FIGS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    FIGS Releases Third Quarter 2025 Financial Results

    Exceeded Expectations on Both Top and Bottom Lines Grew Net Revenues 8.2%, Strongest Quarterly Growth Rate in Two Years Achieved Net Income Margin of 5.8% and Adjusted EBITDA Margin of 12.4% Increasing Full Year 2025 Outlook FIGS, Inc. (NYSE:FIGS) (the "Company"), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released its third quarter 2025 financial results and published a financial highlights presentation on its investor relations website at ir.wearfigs.com/financials/quarterly-results/. Third Quarter 2025 Financial Highlights Net revenues were $151.7 million, an increase of 8.2% year over year, primarily due to an i

    11/6/25 4:05:00 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    FIGS First-Ever Brand to Outfit the Team USA Medical Team at an Olympic and Paralympic Winter Games

    FIGS' celebration of the Team USA Medical Team will take place at the Olympic and Paralympic Winter Games Milano Cortina 2026 FIGS (NYSE:FIGS), the leading global healthcare apparel brand, today announced that its partnership with Team USA will include outfitting 150+ healthcare professionals on the ground at the Milano Cortina 2026 Olympic and Paralympic Winter Games. This marks the first time the Team USA Medical Team will be outfitted at a Winter Games. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251029946723/en/ Building on its successful multi-year partnership with the United States Olympic & Paralympic Committee (USOP

    10/29/25 9:00:00 AM ET
    $FIGS
    Apparel
    Consumer Discretionary

    FIGS Announces Date of Third Quarter 2025 Earnings Release, Conference Call and Webcast

    FIGS, Inc. (NYSE:FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced it will release its third quarter 2025 financial results on Thursday, November 6, 2025, after U.S. markets close. FIGS management will host a conference call that day at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial and business results and outlook. Prior to the call, FIGS will publish a third quarter 2025 financial highlights presentation on its investor relations website at https://ir.wearfigs.com/financials/quarterly-results/default.aspx. FIGS Third Quarter 2025 Earnings and Conference Call Date: Thursday, November 6, 2025 Time: 2:

    10/16/25 4:05:00 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    $FIGS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Oughtred Sarah sold $168,015 worth of shares (22,745 units at $7.39), decreasing direct ownership by 3% to 845,345 units (SEC Form 4)

    4 - FIGS, Inc. (0001846576) (Issuer)

    11/6/25 6:09:26 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    Executive Chair Hasson Heather L. sold $172,528 worth of shares (23,356 units at $7.39), decreasing direct ownership by 2% to 1,274,841 units (SEC Form 4)

    4 - FIGS, Inc. (0001846576) (Issuer)

    11/6/25 6:04:37 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    Chief Financial Officer Oughtred Sarah sold $73,364 worth of shares (9,968 units at $7.36), decreasing direct ownership by 1% to 868,090 units (SEC Form 4)

    4 - FIGS, Inc. (0001846576) (Issuer)

    10/6/25 6:46:16 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    $FIGS
    SEC Filings

    View All

    SEC Form 10-Q filed by FIGS Inc.

    10-Q - FIGS, Inc. (0001846576) (Filer)

    11/6/25 4:24:23 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    FIGS Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - FIGS, Inc. (0001846576) (Filer)

    11/6/25 4:13:59 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    SEC Form 144 filed by FIGS Inc.

    144 - FIGS, Inc. (0001846576) (Subject)

    11/4/25 8:54:42 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    $FIGS
    Financials

    Live finance-specific insights

    View All

    FIGS Releases Third Quarter 2025 Financial Results

    Exceeded Expectations on Both Top and Bottom Lines Grew Net Revenues 8.2%, Strongest Quarterly Growth Rate in Two Years Achieved Net Income Margin of 5.8% and Adjusted EBITDA Margin of 12.4% Increasing Full Year 2025 Outlook FIGS, Inc. (NYSE:FIGS) (the "Company"), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released its third quarter 2025 financial results and published a financial highlights presentation on its investor relations website at ir.wearfigs.com/financials/quarterly-results/. Third Quarter 2025 Financial Highlights Net revenues were $151.7 million, an increase of 8.2% year over year, primarily due to an i

    11/6/25 4:05:00 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    FIGS Announces Date of Third Quarter 2025 Earnings Release, Conference Call and Webcast

    FIGS, Inc. (NYSE:FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced it will release its third quarter 2025 financial results on Thursday, November 6, 2025, after U.S. markets close. FIGS management will host a conference call that day at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial and business results and outlook. Prior to the call, FIGS will publish a third quarter 2025 financial highlights presentation on its investor relations website at https://ir.wearfigs.com/financials/quarterly-results/default.aspx. FIGS Third Quarter 2025 Earnings and Conference Call Date: Thursday, November 6, 2025 Time: 2:

    10/16/25 4:05:00 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    FIGS Releases Second Quarter 2025 Financial Results

    Exceeded Expectations on Both Top and Bottom Lines Grew Net Revenues 5.8% Achieved Net Income Margin of 4.7% and Adjusted EBITDA Margin of 12.9% Increasing Full Year 2025 Outlook FIGS, Inc. (NYSE:FIGS) (the "Company"), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released its second quarter 2025 financial results and published a financial highlights presentation on its investor relations website at ir.wearfigs.com/financials/quarterly-results/. Second Quarter 2025 Financial Highlights Net revenues were $152.6 million, an increase of 5.8% year over year, primarily due to an increase in orders from new and existin

    8/7/25 4:05:00 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    $FIGS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by FIGS Inc.

    SC 13G/A - FIGS, Inc. (0001846576) (Subject)

    11/14/24 1:28:33 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    SEC Form SC 13G filed by FIGS Inc.

    SC 13G - FIGS, Inc. (0001846576) (Subject)

    11/14/24 12:17:49 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by FIGS Inc.

    SC 13G/A - FIGS, Inc. (0001846576) (Subject)

    11/13/24 10:27:59 AM ET
    $FIGS
    Apparel
    Consumer Discretionary

    $FIGS
    Leadership Updates

    Live Leadership Updates

    View All

    FIGS Adds Digital Marketing Executive Jerry Jao as New Independent Director to Its Board of Directors

    FIGS, Inc. (NYSE:FIGS) (the "Company"), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced the appointment of Jerry Jao, former Chief Executive Officer of Retention Science, to its board of directors (the "Board"), effective April 1, 2025 (the "Effective Date"). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250403714974/en/Jerry Jao Mr. Jao joins the Board as an independent director and has also been appointed to serve as both Chair of the Board's Audit Committee and as a member of the Board's Compensation Committee. Since May 2024, Mario Marte has served as

    4/3/25 8:00:00 AM ET
    $FIGS
    Apparel
    Consumer Discretionary

    FIGS Announces Updates to Board of Directors

    FIGS, Inc. (NYSE:FIGS) (the "Company"), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced the appointment of Melanie Whelan, former Chief Executive Officer of SoulCycle Inc., to its board of directors (the "Board"), effective January 1, 2025 (the "Effective Date"). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241219372097/en/Melanie Whelan (Photo: Business Wire) Ms. Whelan joins the Board as an independent director. Ms. Whelan has also been appointed to serve as Chair of the Board's Compensation Committee, which as of the Effective Date will consist of Ms.

    12/19/24 6:50:00 AM ET
    $FIGS
    Apparel
    Consumer Discretionary

    Sarah Oughtred to Become FIGS' New Chief Financial Officer

    Longtime Senior Finance Executive Joins FIGS After Almost 17 Years at lululemon FIGS, Inc. (NYSE:FIGS), the renowned medical apparel brand, today announced the appointment of Sarah Oughtred as the Company's new Chief Financial Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240612619238/en/(Photo: Business Wire) To facilitate a smooth transition, Ms. Oughtred will join FIGS on July 29, 2024, and will become FIGS' Chief Financial Officer, effective August 9, 2024. Ms. Oughtred will lead all aspects of finance, including FP&A and accounting, and will also lead data analytics. "I am thrilled to welcome Sarah to FIGS dur

    6/12/24 6:50:00 AM ET
    $FIGS
    Apparel
    Consumer Discretionary